Rheumatology Advance Access originally published online on February 26, 2008
Rheumatology 2008 47(4):553-554; doi:10.1093/rheumatology/ken008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Association of Kikuchi–Fujimoto's disease with SLE
1Centre for Rheumatology, Department of Medicine, University College London Hospital and 2Arthritis Centre, Northwick Park Hospital, Imperial College London, UK.
Correspondence to: F. Goldblatt, Centre for Rheumatology, Department of Medicine, University College London Hospital, 3rd Floor Central, 250 Euston Road, London NW1 2PQ, UK. E-mail: fgoldblatt@ntlworld.com
| The first 10% of the full text of this article appears below. |
SIR, Kikuchi–Fujimoto's disease (KFD) is a rare benign form of necrotizing histiocytic lymphadenitis, typically affecting young women of Asian background. Clinical features include lymphadenopathy, predominantly involving cervical lymph nodes, fever, malaise, anorexia, myalgias and arthralgias [1]. Diagnosis is dependent upon presence of appropriate immunohistology of the lymph node, which typically shows abundant CD68+ plasmacytoid monocytes in the node paracortex, eosinophilic fibrinoid material and apoptotic debris [2]. KFD has been reported in association with a number of autoimmune and infectious diseases [3, 4], including infrequent co-existence